The Zambia Access to ACT Initiative Survey 2009
Zambia, 2009
Created on
Oct 13, 2011
Last modified
Mar 29, 2019
Page views
98000
Downloads
53194
Consent Granted (f1_07)
Data file: concent
Overview
Valid:
3171
Invalid:
2776
Type:
Discrete
Decimal:
0
Start:
34
End:
34
Width:
1
Range:
-
Format:
Questions and instructions
Literal question
Read Consent Form to Mother/Adult Responsible for The Child. Have them sign below.
Categories
| Value | Category |
|---|---|
| 1 | Yes |
| 2 | No |
| 4 | |
| Sysmiss |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Interviewer instructions
Read Consent form to Mother/Adult Responsible for the Child, Have them sign. (See consent statement below)
Make sure they clearly understand the procedure and have signed the consent form against the eligible persons. If they do not consent to the test, make sure they still sign in the NO space provided.
Make sure they clearly understand the procedure and have signed the consent form against the eligible persons. If they do not consent to the test, make sure they still sign in the NO space provided.
Question post text
CONTEXT:
To match the extraordinary progress in malaria prevention in the past few years, the National Malaria Control Center (NMCC) has put more emphasis on case management and is committed to (i) improve access and guarantee availability of anti-malarial drugs, particularly of the first line drug, Artemisinin Combination Therapies (ACTs), and (ii) ensure that diagnostic tools are available and accessible even in remote areas.
The Zambia Access to ACT Initiative has, upon request by the Government of the Republic of Zambia (GRZ), been designed to inform the GRZ on how to best increase access to life saving malaria treatment (such as ACTs) and to diagnosis that can best target this treatment. The GRZ is emphasizing the use of Rapid Diagnostic Test (RDTs) in malaria testing, a technology that is affordable and can be made more widely accessible than routine microscopy – an important consideration given the size of the rural population in Zambia.
ZAAI SURVEY BIOMEDICAL TESTS OBJECTIVES, SAFETY & PRIVACY STANDARDS:
To help the efforts of the NMCC in improving malaria prevention and case management, as part of the ZAAI survey, we are asking people to take two tests: anemia and malaria. These medical tests are simple and fast to do, completely safe, and painless. We are working with experts from the Tropical Disease Research Centre (TDRC), Zambia, and rely on the protocols developed by the World Health Organization (WHO) to comply with all technical, environmental, and safety procedures. The results will be kept confidential.
TARGET GROUP:
For the anemia and malaria test, we request children under the age of 5 (born after 2004) and all female household members age 15-49 to participate in the biomedical testing, giving a drop of blood obtained through a fingerpick – a simple, virtually painless, and safe testing method.
TEST PROCEDURES:
Malaria is caused by a parasite that infects blood cells. These parasites cause fever and other symptoms common to malaria. Malaria parasites produce chemicals (proteins) called antigens.
• RDT Test: One way to test for malaria parasites is to do a rapid Diagnostic Test (RDT). RDT requires taking a drop of blood obtained through a fingerprick. If malaria antigens are present, the person will test positive. If malaria antigens are not present, the person will test negative. RDTs are completely safe to use for children and adults of all ages including children under 5 years old and recently born infants and cause virtually no pain or discomfort. The kit that will be used has never been used before and will be thrown away after each test. Results are typically given in 15 minutes and can be used to ensure that the sick person gets the most appropriate treatment for his/her illness and therefore has an increased chance of recovering quickly and is less likely to suffer negative long term consequences/effects. The new clinical guidelines, approaved by the Ministry of Health (MOH) and the National Malaria Control Centre (NMCC), encourage the use of RDTs.
• HemoCue Test: Since malaria can be asymptomatic, another way to test for malaria is to look at anemia (low levels of blood). This is done by taking a sample of blood obtained through a fingerprick and examining the sample with a HemoCue machine. Such machines have been in use for the past 25 years. They are clean, completely safe, and endorsed by the MOH.
BENEFITS:
Testing for malaria and anemia is important so that people in these vulnerable target groups (under-five children and women of reproductive age) who have malaria or anemia can be treated in the best way possible way.
Further, these tests will still be useful for those who do not test positive for malaria and/or do not have critical hemoglobin levels, but still have medical complaints. These people will be advised on where to seek consultantion and care in order to establish the true cause of their ill health. Those who will test positive for malaria are going to get Coartem, while those with low Hemoglobin levels will be given Folic Acid.
RISKS:
This is a mildly intrusive procedure that is not painful. You and your child will feel a pinch that will last a few seconds when we take the blood test. This will not cause any harm to your health.
CONFIDENTIALITY:
Any information that is obtained in connection with this study and that can be identified with you will remain confidential and will be disclosed only with your permission. Your responses can be linked to your personal information only through a number that will be kept secure by the survey administrator. The study will focus on the average answer within your community and not on individual answers. The honesty of your answers is very important.
If you have any questions or clarification pertaining to this survey, please feel free to ask. You may also contact [The Principal Operational Research Officer], National Malaria Control Center, Ministry of Health, Lusaka. Tel: 0211 282455.
Thank you very much for your time.
To match the extraordinary progress in malaria prevention in the past few years, the National Malaria Control Center (NMCC) has put more emphasis on case management and is committed to (i) improve access and guarantee availability of anti-malarial drugs, particularly of the first line drug, Artemisinin Combination Therapies (ACTs), and (ii) ensure that diagnostic tools are available and accessible even in remote areas.
The Zambia Access to ACT Initiative has, upon request by the Government of the Republic of Zambia (GRZ), been designed to inform the GRZ on how to best increase access to life saving malaria treatment (such as ACTs) and to diagnosis that can best target this treatment. The GRZ is emphasizing the use of Rapid Diagnostic Test (RDTs) in malaria testing, a technology that is affordable and can be made more widely accessible than routine microscopy – an important consideration given the size of the rural population in Zambia.
ZAAI SURVEY BIOMEDICAL TESTS OBJECTIVES, SAFETY & PRIVACY STANDARDS:
To help the efforts of the NMCC in improving malaria prevention and case management, as part of the ZAAI survey, we are asking people to take two tests: anemia and malaria. These medical tests are simple and fast to do, completely safe, and painless. We are working with experts from the Tropical Disease Research Centre (TDRC), Zambia, and rely on the protocols developed by the World Health Organization (WHO) to comply with all technical, environmental, and safety procedures. The results will be kept confidential.
TARGET GROUP:
For the anemia and malaria test, we request children under the age of 5 (born after 2004) and all female household members age 15-49 to participate in the biomedical testing, giving a drop of blood obtained through a fingerpick – a simple, virtually painless, and safe testing method.
TEST PROCEDURES:
Malaria is caused by a parasite that infects blood cells. These parasites cause fever and other symptoms common to malaria. Malaria parasites produce chemicals (proteins) called antigens.
• RDT Test: One way to test for malaria parasites is to do a rapid Diagnostic Test (RDT). RDT requires taking a drop of blood obtained through a fingerprick. If malaria antigens are present, the person will test positive. If malaria antigens are not present, the person will test negative. RDTs are completely safe to use for children and adults of all ages including children under 5 years old and recently born infants and cause virtually no pain or discomfort. The kit that will be used has never been used before and will be thrown away after each test. Results are typically given in 15 minutes and can be used to ensure that the sick person gets the most appropriate treatment for his/her illness and therefore has an increased chance of recovering quickly and is less likely to suffer negative long term consequences/effects. The new clinical guidelines, approaved by the Ministry of Health (MOH) and the National Malaria Control Centre (NMCC), encourage the use of RDTs.
• HemoCue Test: Since malaria can be asymptomatic, another way to test for malaria is to look at anemia (low levels of blood). This is done by taking a sample of blood obtained through a fingerprick and examining the sample with a HemoCue machine. Such machines have been in use for the past 25 years. They are clean, completely safe, and endorsed by the MOH.
BENEFITS:
Testing for malaria and anemia is important so that people in these vulnerable target groups (under-five children and women of reproductive age) who have malaria or anemia can be treated in the best way possible way.
Further, these tests will still be useful for those who do not test positive for malaria and/or do not have critical hemoglobin levels, but still have medical complaints. These people will be advised on where to seek consultantion and care in order to establish the true cause of their ill health. Those who will test positive for malaria are going to get Coartem, while those with low Hemoglobin levels will be given Folic Acid.
RISKS:
This is a mildly intrusive procedure that is not painful. You and your child will feel a pinch that will last a few seconds when we take the blood test. This will not cause any harm to your health.
CONFIDENTIALITY:
Any information that is obtained in connection with this study and that can be identified with you will remain confidential and will be disclosed only with your permission. Your responses can be linked to your personal information only through a number that will be kept secure by the survey administrator. The study will focus on the average answer within your community and not on individual answers. The honesty of your answers is very important.
If you have any questions or clarification pertaining to this survey, please feel free to ask. You may also contact [The Principal Operational Research Officer], National Malaria Control Center, Ministry of Health, Lusaka. Tel: 0211 282455.
Thank you very much for your time.
Description
Universe
All persons under 5 years and the 15-49 year old females living in this household.